Drax Group (DRXGF)
Drax Statistics
Share Statistics
Drax has 356.55M shares outstanding. The number of shares has increased by -6.66% in one year.
| Shares Outstanding | 356.55M |
| Shares Change (YoY) | -6.66% |
| Shares Change (QoQ) | -2.42% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 349.87M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 4.44 and the forward PE ratio is null. Drax's PEG ratio is -1.06.
| PE Ratio | 4.44 |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | n/a |
| PB Ratio | 1.12 |
| P/FCF Ratio | 4.95 |
| PEG Ratio | -1.06 |
Enterprise Valuation
Drax has an Enterprise Value (EV) of 3.27B.
| EV / Sales | 0.53 |
| EV / EBITDA | 2.97 |
| EV / EBIT | 3.81 |
| EV / FCF | 6.94 |
Financial Position
The company has a current ratio of 1.2, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.2 |
| Quick Ratio | 1 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 1.17 |
| Debt / FCF | 2.74 |
| Interest Coverage | 7.91 |
Financial Efficiency
Return on Equity is 25.35% and Return on Invested Capital is 14.83%.
| Return on Equity | 25.35% |
| Return on Assets | 9.77% |
| Return on Invested Capital | 14.83% |
| Revenue Per Employee | $1.9M |
| Profits Per Employee | $162.03K |
| Employee Count | 3,250 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 14.19 |
Taxes
| Income Tax | 227.9M |
| Effective Tax Rate | 30.25% |
Stock Price Statistics
The stock price has increased by 20.85% in the last 52 weeks. The beta is 0.88, so Drax's price volatility has been higher than the market average.
| Beta | 0.88 |
| 52-Week Price Change | 20.85% |
| 50-Day Moving Average | 7.61 |
| 200-Day Moving Average | 8.03 |
| Relative Strength Index (RSI) | 37.98 |
| Average Volume (20 Days) | 392 |
Income Statement
In the last 12 months, Drax had revenue of 6.16B and earned 526.6M in profits. Earnings per share was 1.37.
| Revenue | 6.16B |
| Gross Profit | 1.88B |
| Operating Income | 850.2M |
| Net Income | 526.6M |
| EBITDA | 1.1B |
| EBIT | 860.9M |
| Earnings Per Share (EPS) | 1.37 |
Balance Sheet
The company has 356M in cash and 1.29B in debt, giving a net cash position of -937.2M.
| Cash & Cash Equivalents | 356M |
| Total Debt | 1.29B |
| Net Cash | -937.2M |
| Retained Earnings | 1.12B |
| Total Assets | 5.39B |
| Working Capital | 308.9M |
Cash Flow
In the last 12 months, operating cash flow was 859.5M and capital expenditures -387.5M, giving a free cash flow of 472M.
| Operating Cash Flow | 859.5M |
| Capital Expenditures | -387.5M |
| Free Cash Flow | 472M |
| FCF Per Share | 1.23 |
Margins
Gross margin is 30.45%, with operating and profit margins of 13.8% and 8.55%.
| Gross Margin | 30.45% |
| Operating Margin | 13.8% |
| Pretax Margin | 12.23% |
| Profit Margin | 8.55% |
| EBITDA Margin | 17.89% |
| EBIT Margin | 13.8% |
| FCF Margin | 7.66% |
Dividends & Yields
DRXGF pays an annual dividend of $0.42, which amounts to a dividend yield of 5.62%.
| Dividend Per Share | $0.42 |
| Dividend Yield | 5.62% |
| Dividend Growth (YoY) | 62.32% |
| Payout Ratio | 23.3% |
| Earnings Yield | 22.54% |
| FCF Yield | 20.2% |
Analyst Forecast
Currently there are no analyst rating for DRXGF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 4.54 |
| Piotroski F-Score | 8 |